Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study.

Saved in:
Bibliographic Details
Title: Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study.
Authors: Zeng Z; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China., Huang H; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Zhu G; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Zeng J; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ye X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Su H; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., He Y; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Jiang Y; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Su M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liu C; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Han C; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liao X; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Mo N; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ma F; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Li T; Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, China., Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liao J; Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Lv Z; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Luo W; Guangxi Key Laboratory of Longevity Science and Technology, AIage Life Science Corporation Ltd., Nanning, China., Wen Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Xu B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Chen B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Peng M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ma J; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Peng T; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Source: Hepatobiliary surgery and nutrition [Hepatobiliary Surg Nutr] 2026 Feb 01; Vol. 15 (1), pp. 6. Date of Electronic Publication: 2025 Feb 24.
Publication Type: Journal Article
Journal Info: Publisher: AME Publishing Company Country of Publication: China (Republic : 1949- ) NLM ID: 101600750 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2304-3881 (Print) Linking ISSN: 23043881 NLM ISO Abbreviation: Hepatobiliary Surg Nutr Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2304-3881
DOI:10.21037/hbsn-24-363